Anastrozole and goserelin combination as first treatment for premenopausal receptor positive advanced or metastatic breast cancer: A phase II trial

被引：0
|
作者：
Roche, H. H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Thierry, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Chieze, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Pierre, K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Veyret, C. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Abadie, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Campone, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Florence, D. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Inst Claudius Regaud, Toulouse, France
[2] Ctr Francois Baclesse, F-14021 Caen, France
[3] CHU Poitiers, Poitiers, France
[4] CRLLC Eugene Marquis, Rennes, France
[5] Ctr Henri Becquerel, F-76038 Rouen, France
[6] Ctr Paul Papin, Angers, France
[7] Ctr Rene Gauducheau, St Herblain, France
[8] Claudius Regaud Hosp, Toulouse, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1079
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase II Trial of Anastrozole Plus Goserelin in the Treatment of Hormone Receptor-Positive, Metastatic Carcinoma of the Breast in Premenopausal Women
    Carlson, Robert W.
    Theriault, Richard
    Schurman, Christine M.
    Rivera, Edgardo
    Chung, Cathie T.
    Phan, See-Chun
    Arun, Banu
    Dice, Kristine
    Chiv, Vivian Y.
    Green, Marjorie
    Valero, Vicente
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3917 - 3921
  • [2] Goserelin plus anastrozole in the treatment of premenopausal hormone receptor positive, recurrent or metastatic breast cancer
    Carlson, R. W.
    Schurman, C. M.
    Rivera, E.
    Chung, C. T.
    Phan, S. C.
    Dice, E. K.
    Thomas, E.
    Valero, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Goserelin plus anastrozole for the treatment of premenopausal women with hormone receptor positive, recurrent/metastatic breast cancer
    Carlson, RW
    Schurmann, CM
    Rivera, E
    Chung, CT
    Phan, SC
    Dice, EK
    Arun, B
    Thomas, E
    Valero, V
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S237 - S238
  • [4] Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Fan, Ying
    Luo, Yang
    Li, Qiao
    [J]. MEDICINE, 2015, 94 (26)
  • [5] Phase II trial of goserelin and exemestane combination therapy in premenopausal women with locally advanced or metastatic breast cancer.
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Luo, Yang
    Cai, Ruigang
    Fan, Ying
    Li, Qiao
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [6] Goserelin plus anastrozole as first-line endocrine therapy for premenopausal women with oestrogen receptor (ER) positive advanced breast cancer (ABC).
    Cheung, KL
    Winterbottom, L
    Owers, R
    Robertson, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 60S - 60S
  • [7] A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer
    Pui San Tan
    Haaland, Benjamin
    Montero, Alberto J.
    Lopes, Gilberto
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (03) : 961 - 965
  • [8] Anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer: A meta-analysis.
    Tan, Pui San
    Haaland, Benjamin
    Montero, Alberto J.
    Lopes, Gilberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] A meta-analysis of anastrozole in combination with fulvestrant in the first line treatment of hormone receptor positive advanced breast cancer
    Pui San Tan
    Benjamin Haaland
    Alberto J. Montero
    Gilberto Lopes
    [J]. Breast Cancer Research and Treatment, 2013, 138 : 961 - 965
  • [10] Changes in bone mineral density caused by anastrozole or tamoxifen in combination with goserelin (± zoledronate) as adjuvant treatment for hormone receptor-positive premenopausal breast cancer:: results of a randomized multicenter trial.
    Gnant, M
    Hausmaninger, H
    Samonigg, H
    Mlineritsch, B
    Taucher, S
    Luschin-Ebengreuth, G
    Jakesz, R
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S31 - S31
12345